Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy-volunteers” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 263
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 263 pipeline programs matching "healthy-volunteers" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

263 results for “healthy-volunteers” Back to intelligence hub

Search results

Page 11 of 11
  1. [14C]-CRN00808

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. [14C]-DNL343

    Denali Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. [14C]-NV-5138

    SUPERNUS PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  4. [14C]-TAK-385 Oral Solution

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  5. [14C]-TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  6. [14C]-TVB-2640

    Sagimet Biosciences

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  7. [14C]-olinciguat

    Cyclerion Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  8. [14C]-praliciguat

    Cyclerion Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  9. anle138b (TEV-56286)

    Teva Pharma GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  10. anti-EGFR monoclonal antibody

    Dragonboat Biopharmaceutical Company Limited

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  11. dMAb AZD5396

    INOVIO PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 1 other completed

    1 trial
  12. firibastat

    Quantum Biopharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. immediate release guanfacine hydrochloride

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. itraconazole

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  15. peficitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. rhPTH(1-84)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. selonabant

    Anebulo Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. tradipitant

    Vanda Pharmaceuticals Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. Nelfinavir and Omeprazole

    Jasper Therapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial
  21. PL-ASA

    Protalix BioTherapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial
  22. Vortioxetine

    Takeda

    Healthy Volunteers

    approved small molecule completed

    1 trial
  23. ketamine

    Cardiff Oncology

    Healthy Volunteers

    approved small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.